Cuts To Science Research Funding Cut American Lives Short − Federal Support Is Essential For Medical Breakthroughs
Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from ...
The Trump Administration Threatens mRNA Research
What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...
Tampa Free Press on MSN4d
NIH Still Spending $1,000,000,000 On DEI Despite Trump’s Order To Cut It Out
The National Institutes of Health (NIH) continues to fund more than a billion dollars in diversity, equity and inclusion programs, even after President Donald Trump ordered federal agencies to ...
STAT4d
This Canadian company’s AI tool could help drugmakers cut risk in late-stage cancer trials
The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal ...
Kentucky Lantern5dOpinion
Medical research cuts will hit red states, rural areas, underserved communities hardest
Trump cuts to the National Institutes of Health will disproportionately hurt red states such as Kentucky that have received ...
STAT5d
Cancer research, long protected, feels ‘devastating’ effects under Trump
Cancer research has had bipartisan support. But Trump administration budget cuts and delays threaten to reverse progress of ...
My son died of a rare cancer — and now funding to find a cure is in jeopardy
Suzanne Vincze is the founder of the Max Vincze Foundation, which funds research for NUT carcinoma at the Dana-Farber Cancer ...
Memorial Sloan Kettering Cancer Center6d
Clinicopathologic and Genomic Discoveries in Metastatic Lung Cancer
Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
EurekAlert!6d
Turchi named inaugural executive director of Tom and Julie Wood Center for Lung Cancer Research
John Turchi, PhD, has been named executive director of the Tom and Julie Wood Center for Lung Cancer Research.
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...